Skip to main content

Translate

"The right test, on the right specimen, collected at the right time, is essential for reliable diagnosis" Dr Prashant Goyal

Clinical significance of NLR, PLR & LMR in COVID-19

The clinical presentation of COVID-19, varies from no symptoms to severe symptoms with complications like acute respiratory failure, acute respiratory distress syndrome, metabolic acidosis, coagulopathy, and septic shock.

A full blood count is a routine, inexpensive and easy test that provides information about formed blood contents. Patients with severe COVID-19 disease present with increased leucocytosis, neutrophilia, lymphopenia, eosinopenia and thrombocytopenia than those with non-severe disease.

Recently, reports on the feasibility of few new haematological parameters like, Neutrophil to Lymphocyte ratio (NLR), Lymphocyte to Monocyte ratio (LMR) and Platelet to Lymphocyte ratio (PLR) in predicting prognosis in patients with SARS-CoV-2 infection have been published. The current study shows that these parameters may be a rapid, cost-effective, widely available, useful prognostic factor in the early screening of critical illness in patients with confirmed COVID-19. These parameters are more sensitive than individual levels of neutrophils, lymphocytes and platelets count. Although further studies with a larger sample size will be needed to properly assess the significance of these parameters in COVID-19.

NLR is an indicator of subclinical systemic inflammation, as neutrophils and lymphocytes play a significant role in inflammation and tumour immunology. NLR may be related to the severity of the infection and also indicates the outcome of the condition. Elevated NLR is found to be an independent prognostic biomarker for COVID-19 patients.

LMR has also been considered as a marker of inflammation including Tuberculosis and various cancers. Low LMR is considered to be a poor prognostic indicator.

PLR is also a novel inflammatory marker. High PLR reflects inflammation, atherosclerosis and platelet activation. Apart from being associated with various diseases, PLR is also an independent prognostic marker to differentiate severe versus non-severe disease in COVID-19 patients.

Early recognition of the severe cases allows for early triaging and timely initiation of management. While many acute phase reactants like C-reactive protein, lactate dehydrogenase, ferritin, and procalcitonin are frequently measured in COVID-19 patients; NLR, LMR and PLR can be easily accessible and are cost-effective especially for developing countries.


Dr Megha Gupta, MD

(Consultant Pathologist, Accuprobe Diagnostics)




Labels:

Comments

Post a Comment

Popular posts from this blog

One Disease, Many Tests: Why Different Tuberculosis (TB) Tests Give Different Results?

Tuberculosis (TB) remains one of the most common infectious diseases worldwide. It is caused by the bacterium Mycobacterium tuberculosis . It most commonly affects the lungs (pulmonary TB), but it can also involve other organs (extra-pulmonary TB), such as the brain, lymph nodes, bones, kidneys, intestines, uterus, and other organs. Although several laboratory and radiological tests are available today, diagnosing TB is not always straightforward. Many patients become confused when one TB test is positive while another is negative. They often wonder, "Which report is correct?" Each TB test looks for a different aspect of the disease. Some detect the bacteria directly, while others detect the body's immune response. Therefore, discrepancies are expected in certain situations. Understanding the strengths and limitations of each test helps prevent unnecessary anxiety and inappropriate treatment. Not every mycobacterium causes tuberculosis. True tuberculosis is caused by memb...
Post a Comment
Read more

From Collection to Analysis: Why Blood Samples Need the Cold Chain

In the field of laboratory medicine, precision is paramount. From sample collection to final analysis, every step must be carefully controlled to ensure that test results are accurate and reliable. One often underestimated but critical aspect of this chain is the maintenance of the cold chain during storage and transportation of blood samples . A lapse at this stage can compromise sample integrity, leading to erroneous results that may adversely affect patient diagnosis and treatment. The cold chain refers to the temperature-controlled supply chain that ensures biological samples like blood, plasma, and serum are kept within specified temperature ranges from the point of collection through storage and transportation until they reach the testing laboratory. Depending on the type of sample and required tests, the temperature may vary. Maintaining these temperatures prevents the degradation of blood components and preserves the biochemical and cellular characteristics essential for accur...
Post a Comment
Read more

The Pitfalls of Routine Health check-ups During Acute Illness: What You Need to Know

Preventive health check-ups , which typically include a series of blood tests, play a crucial role in maintaining overall well-being. These check-ups help identify potential health issues early, allowing for timely intervention. However, while these screenings are essential, the timing of when you undergo them is equally important. Getting routine blood tests during an acute illness—such as the flu, a stomach bug, or even a common cold—can lead to misleading results and unnecessary concerns. Here’s why it’s best to delay preventive health check-ups until after you've fully recovered from an acute illness. Understanding Acute Illness and Its Impact on Blood Tests: An acute illness refers to a sudden onset condition that usually lasts for a short period. Common examples include the flu, fever, a cold, or gastroenteritis (Vomiting, Diarrhoea). Although these illnesses are temporary, they cause significant changes in the body’s physiology as it works to fight off the infection or infla...
Post a Comment
Read more